AegirBio

Today, AegirBio has received funds of $239,547. This award, totaling up to $1.2 million, enables AegirBio AB to commence work towards their continued pursuit of advancements in the field of at-home self-testing.

"We are honored to have received the first installment of the RADx Tech award," said Marco Witteveen, CEO at AegirBioAB. "We are developing a cutting-edge at-home diagnostic platform and a suite of tests that target the digital health market, with a focus on making testing accessible and affordable. This initiative reflects the company’s dedication to revolutionizing healthcare delivery and enhancing patient outcomes.” 

This project has been funded in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health, Department of Health and Human Services, under Contract No. 75N92023D00001.